INCYTE CORP
INCYAPI behind this page
INCY Q1 2026 request
Playground key active
/api/financials?ticker=INCY&year=2026&quarter=1
Pick an endpoint and run the request.
Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Revenue | 1,272,676 | 1,052,898 | +20.9% |
Show Product Lines breakouts |
|||
| ICLUSIG | 35,463 | 29,544 | +20.0% |
| JAKAFI | 757,755 | 709,412 | +6.8% |
| JAKAFI · US | 16.1 | 29.8 | -46.0% |
| JAKAVI Royalty Revenues | 105,556 | 92,145 | +14.6% |
| JAKAVI · Novartis | 105.6 | 92.1 | +14.7% |
| Milestone and contract revenues | 17,000 | — | — |
| Milestone and contract revenues · Reportable Segment | 17,000 | — | — |
| MINJUVI/MONJUVI | 49,227 | 29,551 | +66.6% |
| NIKTIMVO | 55,088 | 13,613 | +304.7% |
| OLUMIANT Royalty Revenues | 36,407 | 30,800 | +18.2% |
| OLUMIANT · Eli Lilly | 36.4 | 30.8 | +18.2% |
| OPZELURA | 143,015 | 118,705 | +20.5% |
| Other product royalty revenues | 3,247 | 1,266 | +156.5% |
| PEMAZYRE | 22,543 | 18,440 | +22.3% |
| Product | 1,104,484 | 922,274 | +19.8% |
| Product · Reportable Segment | 1,104,484 | 922,274 | +19.8% |
| Royalty | 151,192 | 130,624 | +15.7% |
| Royalty · Reportable Segment | 151,192 | 130,624 | +15.7% |
| TABRECTA Royalty Revenues | 5,982 | 6,413 | -6.7% |
| TABRECTA · Novartis | 6 | 6.4 | -6.3% |
| ZYNYZ | 41,393 | 3,009 | +1275.6% |
Show Business Segments breakouts |
|||
| Reportable Segment | 1,272,676 | 1,052,898 | +20.9% |
Show Geography breakouts |
|||
| Europe | 92,429 | 68,612 | +34.7% |
| Other countries | 8,779 | 2,729 | +221.7% |
| US | 1,171,468 | 981,557 | +19.3% |
| Cost of Revenue | 104,523 | 73,188 | +42.8% |
Show Business Segments breakouts |
|||
| Reportable Segment | 104,523 | 73,188 | +42.8% |
Show Geography breakouts |
|||
| US · Syndax | 14.4 | — | — |
| Research & Development | 515,903 | 437,279 | +18.0% |
Show Type Of Arrangement breakouts |
|||
| Syndax | 5.4 | 4.7 | +14.9% |
| Selling, General & Administrative | 328,087 | 325,691 | +0.7% |
| Asset Impairment Charges | 23,214 | — | — |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | -168 | 11,572 | -101.5% |
Show Business Segments breakouts |
|||
| Reportable Segment | -168 | 11,572 | -101.5% |
| Total Costs & Expenses | 971,559 | 847,730 | +14.6% |
| Operating Income | 301,117 | 205,168 | +46.8% |
| Interest Income | 33,687 | 22,929 | +46.9% |
| Interest Expense | -569 | -660 | +13.8% |
| Equity Securities Fv Ni Gain Loss | 6,591 | -1,343 | +590.8% |
| Other Non-Operating Income (Expense) | 2,774 | 8,096 | -65.7% |
| Income Before Taxes | 343,600 | 234,190 | +46.7% |
| Income Tax Expense (Benefit) | 40,270 | 75,987 | -47.0% |
| Net Income | 303,330 | 158,203 | +91.7% |
Show Business Segments breakouts |
|||
| Reportable Segment | 303,330 | 158,203 | +91.7% |
Show Equity Components breakouts |
|||
| Retained Earnings | 303,330 | 158,203 | +91.7% |
| EPS (Basic) | 1.52 | 0.82 | +85.4% |
| EPS (Diluted) | 1.47 | 0.8 | +83.7% |
| Wtd Avg Shares (Basic) | 199,343 | 193,712 | +2.9% |
| Wtd Avg Shares (Diluted) | 206,830 | 198,197 | +4.4% |
| Sales & Marketing (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segment | 259,563 | 257,652 | +0.7% |
| General & Administrative (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segment | 68,524 | 68,039 | +0.7% |
| Comprehensive Income | 300,182 | 165,086 | +81.8% |
| Other Comprehensive Income | -3,148 | 6,883 | -145.7% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | 234 | 512 | -54.3% |
| Accumulated Net Unrealized Investment Gain Loss | -2,485 | 931 | -366.9% |
| Accumulated Other Comprehensive Income | -3,148 | 6,883 | -145.7% |
| Accumulated Translation Adjustment | -897 | 5,440 | -116.5% |
| Net Income Loss Available To Common Stockholders Basic | 303,330 | 158,203 | +91.7% |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 3,461,114 | 1,941,722 | +78.2% |
| Debt Securities Available For Sale Excluding Accrued Interest Current | 554,711 | 466,936 | +18.8% |
| Accounts Receivable Net | 1,051,499 | 823,134 | +27.7% |
| Inventory | 115,624 | 63,975 | +80.7% |
| Prepaid Expenses & Other Current Assets | 301,312 | 211,654 | +42.4% |
| Total Current Assets | 5,484,260 | 3,507,421 | +56.4% |
| Non-Current Assets | |||
| Restricted Cash Noncurrent | 1,836 | 1,665 | +10.3% |
| Equity Securities F V N I Noncurrent | 54,582 | — | — |
Show Fair Value Hierarchy breakouts |
|||
| Fair Value Inputs Level1 · Fair Value Measurements Recurring | 54,582 | — | — |
Show Schedule Of Equity Method Investment Equity Method Investee Name breakouts |
|||
| Investment in Prelude | 21.4 | — | — |
| Investment in Syndax | 33.2 | — | — |
Show Fair Value By Measurement Basis breakouts |
|||
| Estimate Of Fair Value Fair Value Disclosure · Fair Value Measurements Recurring | 54,582 | — | — |
| Inventory Noncurrent | 331,421 | 365,311 | -9.3% |
| Property, Plant & Equipment | 720,169 | — | — |
Show Geography breakouts |
|||
| CH | 304,818 | — | — |
| Other countries | 14,013 | — | — |
| US | 401,338 | — | — |
| Goodwill | 133,000 | 155,593 | -14.5% |
| Deferred Tax Assets | 452,520 | 768,899 | -41.1% |
| Other Non-Current Assets | 24,492 | 30,151 | -18.8% |
| Total Assets | 7,339,113 | 5,749,365 | +27.7% |
| Other Assets | |||
| Finance Lease Right Of Use Asset | 26,669 | 29,892 | -10.8% |
| Other Intangible Assets Net | 110,164 | 107,611 | +2.4% |
| Current Liabilities | |||
| Accounts Payable | 228,624 | 195,537 | +16.9% |
| Employee Related Liabilities Current | 124,920 | 102,820 | +21.5% |
| Accrued Liabilities | 1,092,308 | 1,375,738 | -20.6% |
| Finance Lease Liability Current | 4,413 | 4,478 | -1.5% |
| Business Combination Contingent Consideration Liability Current | 39,384 | 41,717 | -5.6% |
| Total Current Liabilities | 1,489,649 | 1,720,290 | -13.4% |
| Non-Current Liabilities | |||
| Business Combination Contingent Consideration Liability Noncurrent | 70,616 | 153,283 | -53.9% |
| Finance Lease Liability Noncurrent | 29,414 | 32,643 | -9.9% |
| Other Non-Current Liabilities | 126,587 | 175,586 | -27.9% |
| Total Liabilities | 1,716,266 | 2,081,802 | -17.6% |
| Stockholders' Equity | |||
| Common Stock | 200 | 193 | +3.6% |
| Additional Paid In Capital Common Stock | 5,083,234 | 4,588,286 | +10.8% |
| Accumulated Other Comprehensive Income | 22,314 | -6,238 | +457.7% |
| Retained Earnings | 517,099 | -914,678 | +156.5% |
| Total Stockholders' Equity | 5,622,847 | 3,667,563 | +53.3% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | -27,731 | -39,411 | +29.6% |
| Accumulated Net Unrealized Investment Gain Loss | -491 | 1,277 | -138.4% |
| Accumulated Other Comprehensive Income | 22,314 | -6,238 | +457.7% |
| Accumulated Translation Adjustment | 50,536 | 31,896 | +58.4% |
| Additional Paid In Capital | 5,083,234 | 4,588,286 | +10.8% |
| Common Stock | 200 | 193 | +3.6% |
| Retained Earnings | 517,099 | -914,678 | +156.5% |
| Total Liabilities & Equity | 7,339,113 | 5,749,365 | +27.7% |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Net Income | 303,330 | 158,203 | +91.7% |
| Depreciation & Amortization | 23,802 | 22,362 | +6.4% |
| Stock-Based Compensation | 64,126 | 60,982 | +5.2% |
| Deferred Income Taxes And Tax Credits | 63,416 | -6,706 | +1045.7% |
| Other Non-Cash Items | 12,772 | 5,292 | +141.3% |
| Change in Accounts Receivable | -27,027 | 30,955 | -187.3% |
| Change in Prepaid & Other Assets | 9,193 | -62,045 | +114.8% |
| Change in Inventory | -12,226 | -28,574 | +57.2% |
| Change in Accounts Payable | 23,449 | -2,159 | +1186.1% |
| Increase Decrease In Accrued Liabilities | -84,725 | 74,842 | -213.2% |
| Net Cash from Operations | 369,351 | 266,067 | +38.8% |
| Investing Activities | |||
| Payments To Acquire Other Productive Assets | -10,200 | -3,169 | -221.9% |
| Payments To Acquire Intangible Assets | -5,000 | — | — |
| Payments To Acquire Marketable Securities | -142,703 | -41,236 | -246.1% |
| Proceeds From Sale And Maturity Of Marketable Securities | 69,700 | 45,494 | +53.2% |
| Net Cash from Investing | -88,203 | 1,097 | -8140.4% |
| Financing Activities | |||
| Proceeds From Stock Plans | 97,925 | 3,239 | +2923.3% |
| Tax Withholding for Share Compensation | -6,956 | -9,454 | +26.4% |
| Finance Lease Principal Payments | -1,184 | -1,090 | -8.6% |
| Payment For Contingent Consideration Liability Financing Activities | -4,963 | -5,371 | +7.6% |
| Net Cash from Financing | 84,822 | -12,676 | +769.2% |
| Supplemental | |||
| Income Taxes Paid | -8,787 | 844 | -1141.1% |
| Unpaid Capital Expenditures | 1,633 | 2,890 | -43.5% |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 572 | 1,171 | -51.2% |
| Right Of Use Asset Obtained In Exchange For Finance Lease Liability | 279 | 220 | +26.8% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -2,689 | -552 | -387.1% |
| Net Change in Cash | 363,281 | 253,936 | +43.1% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 3,462,950 | 1,943,387 | +78.2% |
Values in thousands USD. Source: SEC EDGAR 10-Q filing.